Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancerBrittney S. Harrington, John D. Hooper, Mark N. Adams et al.|British Journal of Cancer|2016Cited by 82
Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancerBrittney S. Harrington, John D. Hooper|Theranostics|2020Cited by 31